The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
Walk-in patients with typical upper respiratory tract infections have increased; many also reporting gut-related ailments ...
More than 90% of Omvoh-treated patients who were in clinical remission at one year sustained it with two years of continuous treatment Nearly 90% of ...
KMOV St. Louis on MSN3d
Nasal COVID vaccine developed at WashU approved for clinical trialsThe Food and Drug Administration (FDA) recently gave approval for clinical trials in the U.S. of a COVID-19 nasal vaccine ...
Nasal irrigation can be a useful addition to the management of chronic upper respiratory conditions, including nasal ...
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
A cough and cold outbreak in Kolkata has left thousands with sore throats and a temporary loss of voice. The infection lasts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback